Shots:
- The US FDA has granted 510(k) clearance to cobas Respiratory 4-flex, which utilizes TAGS technology for simplification of respiratory testing & improving diagnostic speed as well as accuracy
- The cobas Respiratory 4-flex integrates seamlessly with cobas 5800, 6800 & 8800 systems to allow qualitative detection & differentiation of SARS-CoV-2, influenza A/B, as well as respiratory syncytial virus in nasopharyngeal swab samples from symptomatic pts
- TAGS (Temperature-Activated Generation of Signal) technology combines multiplex PCR with color, temperature, & data analysis to detect & distinguish multiple targets simultaneously within a single optical channel
Ref: Roche | Image: Roche| Press Release
Related News:- Roche Reports P-III (Portal) Trial Data on Susvimo for Neovascular Age-Related Macular Degeneration (nAMD)
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
